Submission of Letter of Offer for Buy- Back upto 16,00,000 Equity Shares at price of INR-250/- per share amounting to INR-40,00,00,000/-

Corporate Actions View source PDF Explain this filing

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹210.00

prior close

₹210.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.6%+0.5% vs market

Pharmaceuticals peers, median of 165sector+0.4%+1.6% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.5

15m

-0.6

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0+1.6+0.5+0.4+1.6

Next day

+3.5+1.5+2.0+0.5+3.0

-0.5+0.0-0.6+0.7-1.3

+1.0-3.0+4.0-1.0+2.0

+0.2-2.4+2.6-1.4+1.7

-1.7-2.1+0.5-0.5-1.1

-5.3-3.8-1.4-1.7-3.6

15d

-1.9-0.0-1.9+1.1-3.0

-6.0-1.0-5.0-0.6-5.4

+13.8+6.5+7.3+4.1+9.7

+10.2+10.2+0.1+6.1+4.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jagsonpal Pharmaceuticals Ltd is undertaking a buyback of up to 16 lakh fully paid-up equity shares (2.38% of total paid-up capital) at ₹250 per share via tender offer route through stock exchanges. The total buyback size is ₹40 crore, representing 18.35% of the company's aggregate paid-up capital and free reserves as per FY2025 financials, well within the statutory 25% limit. The record date for determining eligible shareholders is May 04, 2026. The buyback window opens on May 08, 2026 and closes on May 14, 2026, with settlement expected by May 21, 2026. The buyback is being funded from internal accruals and cash balances. Small shareholders holding shares worth up to ₹2 lakh as on record date are reserved a portion of the buyback.

Likely market impact

Shareholders can tender their shares at ₹250 per share, receiving cash directly. The buyback will reduce outstanding shares and could support the stock price, though the company deploys ₹40 crore in cash for the program.